UV Flu Technologies, Inc. (UVFT)

Market Cap	13.42K -99.3%
Revenue (ttm)	194.75K +43.5%
Net Income	-750.44K
EPS	-0.01
Shares Out	134.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,000
Average Volume	30,626
Open	0.0001
Previous Close	0.0002
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0002
Beta	-67.22
RSI	48.13
Earnings Date	n/a

About UV Flu Technologies

UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes. The company also offers RX Air product line, which include HEPA based air purifiers. Its products are used in hotels, hair and nail salons, pet kennels, test labs, hospitals, restaurants, casin...

• Industry: Pollution & Treatment Controls
• Sector: Industrials
• Founded: 2006
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: UVFT

Financial Performance

In fiscal year 2015, UV Flu Technologies's revenue was $175,513, an increase of 54.31% compared to the previous year's $113,743. Losses were -$946,666, -4.70% less than in 2014.